Jan Pegg

Phase I study of replication-competent adenovirus-mediated double suicide gene therapy for the treatment of locally recurrent prostate cancer.

Svend O. Freytag, Mark S. Khil, Hans Stricker et al. · PubMed · 2002 · 312 citations

Infectious Adenovirus, Replication-competent Adenovirus, Recurrent Prostate Cancer +18

Phase I study of replication-competent adenovirus-mediated double-suicide gene therapy in combination with conventional-dose three-dimensional conformal radiation therapy for the treatment of newly diagnosed, intermediate- to high-risk prostate cancer.

Svend O. Freytag, Hans Stricker, Jan Pegg et al. · PubMed · 2003 · 265 citations

Radiation Medicine, Urology, High-risk Prostate Cancer +13

Acupuncture Versus Venlafaxine for the Management of Vasomotor Symptoms in Patients With Hormone Receptor–Positive Breast Cancer: A Randomized Controlled Trial

Eleanor Walker, Alba I. Rodríguez, Beth Kohn et al. · Journal of Clinical Oncology · 2009 · 221 citations · Full text

Phase I Trial of Replication-competent Adenovirus-mediated Suicide Gene Therapy Combined with IMRT for Prostate Cancer

Svend O. Freytag, Benjamin Movsas, I. Aref et al. · Molecular Therapy · 2007 · 145 citations · Full text

Phase I Study of Noninvasive Imaging of Adenovirus-mediated Gene Expression in the Human Prostate

Kenneth Barton, Hans Stricker, Stephen L. Brown et al. · Molecular Therapy · 2008 · 140 citations · Full text